Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for i antigen
Most Correlated Studies
- Response to IL-12 and Type I IFN with or without TCR and CD28 T-lymphocyte stimulation
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Most Relevant Literature
- Characterization of CD4 T-cell phenotype in human leukocyte antigen class II-positive acral melanoma…
- Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molec…
- MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T-…
- TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning.
- Successful transatlantic bilateral hand transplant in a young female highly sensitized to HLA class …
Most Relevant Clinical Trials
- Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus
- Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Pros…
- A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321
- Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
- Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cance…
